Medication info
Tenegliptin Extended-Release Tablets 10/750 mg (Tenegliptin Hydrochloride Hydrate, Metformin Hydrochloride)

Tenegliptin Extended-Release Tablets 10/750 mg (Tenegliptin Hydrochloride Hydrate, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Hanpoong Pharmaceutical Co., Ltd.
Appearance
Yellow oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201293 · Approved 2022.04.01 · Insurance code 658108340

Summary

Main use
Improves glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered with a sulfonylurea, reducing the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to this medicine from another glucose-lowering medicine. Because such a change may affect blood glucose control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Hanpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improves glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes to control their blood sugar more effectively. It is particularly suitable for patients who are also following dietary and exercise regimens, and it improves blood sugar control by combining tenegliptin and metformin. This significantly aids patients in managing their diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's current doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered with a sulfonylurea, reducing the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to this medicine from another glucose-lowering medicine. Because such a change may affect blood glucose control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication is used for controlling blood sugar. However, there are several points to be cautious about when taking this medication. First, it can rarely cause a serious condition called lactic acidosis. Lactic acidosis can be dangerous due to excessive accumulation of lactic acid in the body, so if symptoms such as lethargy, abdominal pain, or difficulty breathing occur, consult a doctor immediately. Second, taking it alongside other diabetes medications or insulin can cause hypoglycemia, so it is important to monitor blood sugar levels carefully. Third, patients with impaired kidney function, severe heart disease, liver dysfunction, or those with severe infection or traumatic systemic disorders should not take this medication. Fourth, stop taking this medication at least 48 hours before undergoing tests that use iodine contrast agents, and only resume after confirming normal kidney function post-examination. Fifth, it is advisable for pregnant women or women who could become pregnant, individuals with very poor nutritional status, or patients who are in a state of starvation or weakness not to take this medication. Sixth, avoid alcohol intake while taking this medication, and especially be cautious in situations where acute alcohol intoxication is a risk. Seventh, side effects such as gastrointestinal disturbances, dizziness, joint pain, and skin rashes may occur in some patients, so report any unusual symptoms to a doctor. Finally, elderly patients or those with reduced kidney function should have regular kidney function tests and adjust their dosage as necessary. It is essential to be aware of symptoms of hypoglycemia and lactic acidosis while taking this medication, and to consult healthcare personnel immediately if symptoms arise.

Side effects

  • Severe lactic acidosis
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • bullous pemphigoid
  • acute pancreatitis
  • dizziness
  • abdominal distension
Show 183 more
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • elevated amylase
  • elevated lipase
  • increased AST(GOT)
  • increased ALT(GPT)
  • elevated GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK(CPK)
  • increased serum potassium concentration
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • headache
  • tremors
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • shortness of breath
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophils
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament calcification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • paresthesia
  • hepatic coma
  • sensory disorders
  • sensory impairment
  • tension headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • orthostatic dizziness
  • muscle weakness
  • low back pain
  • limb pain
  • lumbar spinal canal stenosis
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformity
  • hypertrophic osteoarthritis
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament calcification
  • spinal foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • gastroenteritis
  • influenza
  • nasopharyngitis
  • uterine abscess
  • subcutaneous abscess
  • gastroenteritis
  • musculoskeletal chest pain
  • arthralgia
  • intervertebral disc degeneration
  • headache
  • chronic bronchitis
  • goiter
  • hypercholesterolemia
  • hypertension
  • urticaria
  • vomiting
  • upper abdominal pain
  • abdominal pain
  • gastrointestinal motility disorder
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • shortness of breath
  • exertional dyspnea
  • atelectasis
  • epistaxis
  • chest discomfort
  • fever
  • chills
  • generalized edema
  • injection site inflammation
  • chest pain
  • dysuria
  • renal cyst
  • nocturia
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • bruise
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to keep air out, with a recommended storage temperature between 1 degree and 30 degrees Celsius. Proper storage maintains the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

Yellow oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.